Status:
COMPLETED
Molecular Characterization of Penile Cancers in Developing Countries
Lead Sponsor:
Latin American Cooperative Oncology Group
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Penile Squamous Cell Carcinoma
Eligibility:
MALE
18+ years
Brief Summary
This study explores penile squamous cell carcinoma (PSCC) in Brazil, a rare cancer associated with factors like poor hygiene and HPV infection, using next-generation sequencing to investigate its geno...
Detailed Description
This study focuses on penile squamous cell carcinoma (PSCC), a rare cancer that is more prevalent in underdeveloped regions such as Africa, Asia, and South America, with Brazil having one of the highe...
Eligibility Criteria
Inclusion
- Men ≥ 18 years of age;
- Diagnosis of locally advanced or metastatic squamous-cell penile carcinoma;
- Have received at least one treatment for advanced disease (surgery, radiotherapy and/or chemotherapy);
- Available representative tumor block of formalin-fixed and paraffin-embedded (FFPE) archive, from primary or metastasis;
- Patients must be already deceased at time of data collection.
Exclusion
- Patients without medical record available (lost, empty or irretrievable clinical information).
Key Trial Info
Start Date :
December 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 3 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06068998
Start Date
December 17 2021
End Date
August 3 2023
Last Update
October 5 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncocentro Ceará
Fortaleza, Ceará, Brazil
2
Hospital Universitário da Universidade Federal do Maranhão (UFMA)
São Luís, Maranhão, Brazil, 65080-805
3
Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil